Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.26355/eurrev_202004_21037 http://scihub22266oqcxt.onion/10.26355/eurrev_202004_21037 32373992!ä!32373992 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Rev+Med+Pharmacol+Sci 2020 ; 24 (8): 4537-4538 Nephropedia Template TP {{tp|p=32373992|t=2020. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment |pdf=|usr=}}{{32373992}} gab.com Text MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment JO: Eur Rev Med Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32373992 #FOAvip At present, SARS-Cov-2 is spread all over the world, becoming a serious threat to people's health. SARS-Cov-2 has a strong infection, and the mortality rate of severe patients after infection is high, but there is no effective treatment. Mesenchymal stem cells (MSCs) have anti-inflammatory and immunomodulatory functions, which can reduce the occurrence of cytokine storm syndrome and acute respiratory distress syndrome. At the same time, MSCs can reduce the level of pulmonary fibrosis and enhance tissue injury repair. In this short report, combined with the progress of preclinical and clinical research, we comment the efficacy of MSCs in the treatment of COVID-19. Twit Text FOAVip MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment ????Eur Rev Med Pharmacol Sci http://www.kidney.de/pget.php?&tw=1&pmid=32373992 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32373992 #FOAvip English Wikipedia <ref>{{Cite pmid|32373992}}</ref> MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment #MMPMID32373992 Wang XY Eur Rev Med Pharmacol Sci 2020[Apr]; 24 (8): 4537-4538 PMID32373992show ga At present, SARS-Cov-2 is spread all over the world, becoming a serious threat to people's health. SARS-Cov-2 has a strong infection, and the mortality rate of severe patients after infection is high, but there is no effective treatment. Mesenchymal stem cells (MSCs) have anti-inflammatory and immunomodulatory functions, which can reduce the occurrence of cytokine storm syndrome and acute respiratory distress syndrome. At the same time, MSCs can reduce the level of pulmonary fibrosis and enhance tissue injury repair. In this short report, combined with the progress of preclinical and clinical research, we comment the efficacy of MSCs in the treatment of COVID-19. |*Mesenchymal Stem Cell Transplantation[MESH] |Animals[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*therapy[MESH] |Cytokines/adverse effects/immunology[MESH] |Humans[MESH] |Immunomodulation[MESH] |Pandemics[MESH] |Pneumonia, Viral/*therapy[MESH] |Pulmonary Fibrosis/therapy[MESH] |Respiratory Distress Syndrome/therapy[MESH]MSCs transplantation may be a potential therapeutic strategy for COVID(epmc).pdf DeepDyve Pubget Overpricing